Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GST-HG131, a dihydrobenzopyridooxazepine (DBP) series compound, specifically inhibits hepatitis B virus (HBV) surface antigen. It demonstrates excellent HBV antigens inhibition, with EC50 values of 28.2 nM (HBsAg) and 16.0 nM (HBeAg), respectively, and is safe for animal use.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,650.00 | |
50 mg | 10-14 weeks | $ 2,150.00 | |
100 mg | 10-14 weeks | $ 3,310.00 |
Description | GST-HG131, a dihydrobenzopyridooxazepine (DBP) series compound, specifically inhibits hepatitis B virus (HBV) surface antigen. It demonstrates excellent HBV antigens inhibition, with EC50 values of 28.2 nM (HBsAg) and 16.0 nM (HBeAg), respectively, and is safe for animal use. |
Molecular Weight | 431.48 |
Formula | C23H29NO7 |
CAS No. | 2270215-69-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GST-HG131 2270215-69-3 GST-HG-131 LB 42908. LB-42908 GST-HG 131 inhibitor inhibit